Related Experiment Video

Updated: Aug 19, 2026

Assessing Specificity of Anticancer Drugs In Vitro
09:39

Assessing Specificity of Anticancer Drugs In Vitro

Published on: March 23, 2016

RNA:DNA ratios in human tumors

L Kravetz de Srulijes, E Israeli, D Barzilai

    Journal of the National Cancer Institute
    |March 1, 1977
    PubMed

    Abstract:

    A study has been made of the quantitative relation existing between the RNA:DNA ratios in benign and in malignant human tumors. It has been demonstrated that a significant difference (Student's t-test) existed between malignant and benign human tumors within the different groups studied: a) malignant and benign breast tumors (t=2.22, P less than 0.05); b) Hodgkin's disease in spleen and its controls (t=2.39, P less than 0.02); and c) malignant and benign thyroid tumors (t=4.23, P less than 0.01). The diagnostic value of this finding is discussed.

    More Related Videos

    Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
    13:24

    Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

    Published on: April 11, 2016

    Detection of Rare Mutations in CtDNA Using Next Generation Sequencing
    11:11

    Detection of Rare Mutations in CtDNA Using Next Generation Sequencing

    Published on: August 24, 2017

    Related Experiment Videos

    Last Updated: Aug 19, 2026

    Assessing Specificity of Anticancer Drugs In Vitro
    09:39

    Assessing Specificity of Anticancer Drugs In Vitro

    Published on: March 23, 2016

    Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
    13:24

    Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

    Published on: April 11, 2016

    Detection of Rare Mutations in CtDNA Using Next Generation Sequencing
    11:11

    Detection of Rare Mutations in CtDNA Using Next Generation Sequencing

    Published on: August 24, 2017

    Related Concept Videos

    Nucleotide Excision Repair01:08

    Nucleotide Excision Repair

    Overview
    Nucleotide Excision Repair01:38

    Nucleotide Excision Repair

    DNA Distortion and Damage
    Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...

    Articles linked to this work by shared authors, journal, and citation graph.

    Rare coding variant analysis in a large cohort of Ashkenazi Jewish families with inflammatory bowel disease.

    Human genetics·2018

    Oral administration of non-absorbable delayed release 6-mercaptopurine is locally active in the gut, exerts a systemic immune effect and alleviates Crohn's disease with low rate of side effects: results of double blind Phase II clinical trial.

    Clinical and experimental immunology·2015

    The impact of abdominal computed tomography in a tertiary referral centre emergency department on the management of patients with inflammatory bowel disease.

    Alimentary pharmacology & therapeutics·2013

    When APS (Hughes syndrome) met the autoimmune/inflammatory syndrome induced by adjuvants (ASIA).

    Lupus·2012

    Gulf War syndrome as a part of the autoimmune (autoinflammatory) syndrome induced by adjuvant (ASIA).

    Lupus·2012

    Vaccination of patients with auto-immune inflammatory rheumatic diseases requires careful benefit-risk assessment.

    Autoimmunity reviews·2011

    Timing of mental disorders in relation to cancer-specific mortality in cancer patients.

    Journal of the National Cancer Institute·2026

    Addressing the impact of tobacco and alcohol use on cancer-related health outcomes.

    Journal of the National Cancer Institute·2026

    Epigenetic aging of colorectal mucosa in cancer development.

    Journal of the National Cancer Institute·2026

    Randomized trial of adjuvant 5-FU-platinum vs paclitaxel-platinum for high-risk penile cancer.

    Journal of the National Cancer Institute·2026

    Concurrent chemotherapy and external radiation therapy (ConCERT): phase 3 noninferiority randomized clinical trial of cisplatin weekly vs every 3 weeks in locally advanced squamous cell carcinoma of the head and neck.

    Journal of the National Cancer Institute·2026

    Evaluating longitudinal toxicity and adverse event in cetuximab-treated metastatic colorectal cancer: a pooled analysis from 1,302 patients in ARCAD database.

    Journal of the National Cancer Institute·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us